Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00199953 · ClinicalTrials.gov registry record · Phase 2
Post-nasal Drainage as an Extraesophageal Manifestation of Reflux
A Phase 2 study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00199953: Completed Phase 2 study, sponsored by Medical College of Wisconsin.
NCT00199953 is a Phase 2 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 50 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00199953, a Phase 2 study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
Objectives of this study are: * To quantitatively evaluate the relationship between extraesophageal manifestations of gastroesophageal reflux (EER) and postnasal drainage(PND)in a group of patients without radiographic or endoscopic evidence of sinonasal inflammatory disease. * To assess the efficacy of BID proton pump inhibitors (PPI) in the management of patients with symptomatic postnasal drainage.
Interventions
- DRUG Rabeprazole 20 mg twice a day for 90-day period treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2002-06 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
What the finished NCT00199953 record still lists
NCT00199953 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 1 intervention - of which Rabeprazole 20 mg twice a day for 90-day period treatment is the first listed.
NCT00199953 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00199953 about?
NCT00199953 is a clinical study titled "Post-nasal Drainage as an Extraesophageal Manifestation of Reflux". Objectives of this study are: * To quantitatively evaluate the relationship between extraesophageal manifestations of gastroesophageal reflux (EER) and postnasal drainage(PND)in a group of patients without radiographic or endoscopic evidence of sinonasal inflammatory disease. * To assess the effica...
What is the current status of trial NCT00199953?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2002-06. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00199953?
The interventions under investigation include: Rabeprazole 20 mg twice a day for 90-day period treatment (DRUG).
Who is sponsoring clinical trial NCT00199953?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00199953's enrollment target sits among peer trials
50 1195th of 2000 higher than 740 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia